Dr. John D. Reveille, MD

Dr. Reveille practices at Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX.

Dr. Reveille's NPI, 1295753408, was assigned on July 17, 2006. Dr. Reveille graduated from The Johns Hopkins University School of Medicine in 1977. Dr. Reveille's Texas license number on file is H3153.

Dr. Reveille's primary practice is Harris Health Ben Taub Hospital, at 1504 Taub Loop, Houston, TX 77030 in Harris County. The practice phone is (713) 873-2000.

Dr. Reveille's primary practice is Harris Health Ben Taub Hospital in Houston, Texas, part of Harris County, TX. Dr. Reveille is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is UT Physicians. Dmand AI also links Dr. Reveille to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reveille practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Reveille's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Reveille is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Reveille's licenses on file in 4 states: Texas, Florida, Alabama and Maryland.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, osteoporosis and rheumatoid arthritis among the conditions Dr. Reveille treats.

CMS data shows 374 Medicare services from Dr. Reveille across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $13,036 for them. Every service was in an office.

CMS counts 78 Medicare patients who saw Dr. Reveille in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have arthritis, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reveille's median patient age at 61, with 50% women.

In 2024, Dr. Reveille wrote 543 Medicare Part D claims for 72 patients. 77% of them were for generic drugs. CMS names the drug for 385 of them, across 15 drugs with 11 or more claims each, at $418,902 in total drug cost. In 2023, CMS named 346 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Reveille for performance year 2024, reported as part of a group. Dr. Reveille accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 435 papers to Dr. Reveille, published from 2003 to 2024. 2015 was the busiest year, with 12. The most frequent topics are Lupus Erythematosus, Systemic, White People and Genetic Predisposition to Disease. Dr. Reveille has published most often in Arthritis Rheum. Dr. Reveille's most frequent co-authors are Judith A. James, MD, PhD, Maureen D. Mayes, MD and Shervin Assassi, MD.

Dmand AI links Dr. Reveille to 5 clinical trials. Conditions studied include Axial Spondyloarthritis, Spondylitis, Ankylosing and Bone Diseases, Infectious. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Reveille that name 3 trials.

CMS Open Payments shows 153 general payments to Dr. Reveille from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Janssen Pharmaceuticals, Inc paid the most, $76,759. It also lists 11 research payments totaling $38,236 from 2017 to 2022, naming 3 clinical trials.

Dmand AI lists 2 awards for Dr. Reveille, most recently Top Doctors:SE Texas in 2013.

Dr. Reveille graduated from The Johns Hopkins University School of Medicine in 1977. Dr. Reveille is a member of ACR and ACR.

Dr. Reveille is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.